Yuefeng Yang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- CAR-T cell therapy research
Papers in
-
- Circular RNAs in diseases 7
- Fibroblast Growth Factor Research 3
-
- MicroRNA in disease regulation 7
- Cancer, Hypoxia, and Metabolism 5
- Cancer-related molecular mechanisms research 3
- Co-authors
- Fengjun Xiao (15 shared papers)Lisheng Wang (5 shared papers)Hua Wang (9 shared papers)Prem Seth (10 shared papers)Cheng Zhou (3 shared papers)Linggang Wang (3 shared papers)Yuanxiang Jin (3 shared papers)Zhengwei Fu (3 shared papers)
- Journals
- Human Gene Therapy (5 papers)Biochemical and Biophysical Research Communications (5 papers)Molecular Therapy (2 papers)Cancer Gene Therapy (2 papers)Molecular Neurobiology (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yuefeng Yang
33 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 387
- Oncology 273
- Molecular Biology 588
- Health, Toxicology and Mutagenesis 117
- Biotechnology 72
Countries citing papers authored by Yuefeng Yang
This map shows the geographic impact of Yuefeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuefeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuefeng Yang more than expected).
Fields of papers citing papers by Yuefeng Yang
This network shows the impact of papers produced by Yuefeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuefeng Yang. The network helps show where Yuefeng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuefeng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 141 | |
| 2 | 2011 | 91 | |
| 3 | 2011 | 75 | |
| 4 | 2011 | 75 | |
| 5 | 2020 | 69 | |
| 6 | 2015 | 63 | |
| 7 | 2015 | 47 | |
| 8 | MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27. | 2014 | 47 |
| 9 | 2019 | 45 | |
| 10 | 2017 | 40 | |
| 11 | Andrographolide presents therapeutic effect on ulcerative colitis through the inhibition of IL-23/IL-17 axis. | 2018 | 39 |
| 12 | 2016 | 33 | |
| 13 | 2014 | 30 | |
| 14 | 2016 | 29 | |
| 15 | 2010 | 29 | |
| 16 | 2014 | 27 | |
| 17 | 2018 | 22 | |
| 18 | 2020 | 21 | |
| 19 | 2011 | 21 | |
| 20 | 2016 | 20 |
About Yuefeng Yang
Yuefeng Yang is a scholar working on Molecular Biology, Cancer Research, Genetics, Biotechnology and Oncology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), Cancer Research and Treatments (9 papers), MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (7 papers), Cancer, Hypoxia, and Metabolism (5 papers), CAR-T cell therapy research (3 papers), Cancer-related molecular mechanisms research (3 papers) and Fibroblast Growth Factor Research (3 papers). The work is most often cited by research in Cancer Research (387 citations), Oncology (273 citations), Molecular Biology (588 citations), Health, Toxicology and Mutagenesis (117 citations) and Biotechnology (72 citations). Yuefeng Yang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Fengjun Xiao, Lisheng Wang, Hua Wang, Prem Seth, Cheng Zhou, Linggang Wang, Yuanxiang Jin, Zhengwei Fu, Yuxiang Li and Dan Zhang. Their work appears in journals such as Human Gene Therapy, Biochemical and Biophysical Research Communications, Molecular Therapy, Cancer Gene Therapy and Molecular Neurobiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.